Where does Jiangsu Micromedmark Biotech Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jiangsu Micromedmark Biotech Co., Ltd. ranks #26,636 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jiangsu Micromedmark Biotech Co., Ltd. hold?

Jiangsu Micromedmark Biotech Co., Ltd. holds 10 US utility patents granted between 2016 and 2022, spanning 8 technology areas.

What is Jiangsu Micromedmark Biotech Co., Ltd.'s Innovation Score?

Jiangsu Micromedmark Biotech Co., Ltd. has an Innovation Score of 25.6 out of 100 (18th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Jiangsu Micromedmark Biotech Co., Ltd.'s patent grant rate increasing or decreasing?

Jiangsu Micromedmark Biotech Co., Ltd.'s recent grant velocity is -57% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Jiangsu Micromedmark Biotech Co., Ltd.'s patents?

Jiangsu Micromedmark Biotech Co., Ltd.'s patents average 9.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jiangsu Micromedmark Biotech Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Jiangsu Micromedmark Biotech Co., Ltd.

Q: What technology areas does Jiangsu Micromedmark Biotech Co., Ltd. focus on?

Jiangsu Micromedmark Biotech Co., Ltd.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 9 patents, ranking #1,126 of 4,144 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2016–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jiangsu ranks #26,636 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.

#26,636
of 49,997 US assignees by volume: 18th percentile
by Innovation Score (25.6/100): 9.9
avg claims per patent: -57%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26636 · Foreign Corporation #26,636 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,636/49,997
PHOTO-FINISH JFE Engineering
CPC-NARROW C12N · 8 areas
INNOV-THIN 25.6/100
CLAIMS-PAR 9.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -57% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: JFE Engineering Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Jiangsu’s 25.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (33%) Velocity 1.3 pts (5%) Breadth 10.0 pts (39%) Claim depth 5.9 pts (23%)

Qualcomm Incorporated · highest

85
Jiangsu Micromedmark… · this assignee

26
3D Lighting… · lowest

7

What this shows Jiangsu's Innovation Score is 25.6/100 (18th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Jiangsu?

Each dot is one of Jiangsu’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jiangsu’s own 9.9 claims/patent is at or below the 10.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Jiangsu vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Jiangsu's grants concentrate

Jiangsu Micromedmark Biotech Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 90% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2016. By volume, Jiangsu sits between JFE Engineering Corporation and Jordan University OF Science AND Technology.

Jiangsu's three-year grant acceleration

Jiangsu Micromedmark Biotech Co., Ltd. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

JFE Engineering

10
Jiangmen City Xin…

10
Jiangsu Electric…

10
Jiangsu Kanion Ph…

10
JJC Imports

10
JN Biosciences

10
Jolife AB

10
Jordan University…

10
Jiangsu Micromedm… ◀

10

What this shows Jiangsu holds 10 patents at rank #26,624, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jiangsu

By rank, the assignees closest to #26,624 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Jiangsu's primary technology class.

Jiangsu's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

26 18th percentile higher than 18% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Jiangsu Micromedmark Biotech Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	10.0%
2018	3	30.0%
2019	3	30.0%
2020	1	10.0%
2021	1	10.0%
2022	1	10.0%

Which technologies does Jiangsu Micromedmark Biotech Co., Ltd. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

Y02A - Technologies FOR Adaptation TO Climate Change 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

C12Y - Enzymes 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Jiangsu Micromedmark Biotech Co., Ltd.'s patent record in context - here's where to go next.

Jiangsu Micromedmark Biotech Co., Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 90% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #26,636 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jiangsu Micromedmark Biotech Co., Ltd. against JFE Engineering Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.